003120.KS
Ilsung Is Co., Ltd.
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 20,650.00
+0.49%Margins
Gross margin
42.0%
EBITDA margin
-5.0%
EBIT margin
-7.5%
Net margin
8.5%
FCF margin
8.3%
1.5%
Return on equity
1.4%
Return on assets
-1.3%
Return on invested capital
0.16x
Asset turnover
KRW 7.1B
Cash from operations
KRW 15.9K
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026